HCAT Health Catalyst, Inc.: institutional ownership and insider trading
137 funds reported holding $128M of Health Catalyst, Inc. in their latest 13F filings; in Q2 2026 funds net sold $6.10M, with 32 new positions and 34 funds selling out; over the last 12 months insiders bought $106K and sold $201K on the open market.
Famous investors holding HCAT
- Ken Griffin (Citadel Advisors): $1.09M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $1.03M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $695K, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $27.3K, 0.0% of the portfolio
Largest institutional holders of HCAT
- First Light Asset Management, LLC — $25.5M
- CDC Financial, Inc. — $14.1M
- VANGUARD GROUP INC — $10.6M
- Palogic Value Management, L.P. — $9.80M
- Impax Asset Management Group plc — $7.96M
- VANGUARD CAPITAL MANAGEMENT LLC — $5.91M
- Nepsis Inc. — $5.17M
- Caption Management, LLC — $4.92M
- Nuveen Asset Management, LLC — $4.20M
- BlackRock, Inc. (BLK) — $3.65M
Recent HCAT insider trades
- Sep 14, 2026: Kohl Simeon bought 59,000 shares ($106K)
- Dec 5, 2025: Landry Benjamin sold 27,425 shares ($72.4K)
- Dec 4, 2025: Larson-Green Julie sold 47,997 shares ($128K)
- Sep 5, 2025: Landry Benjamin sold 6,175 shares ($20.7K)
5%+ owners
- COGHILL CLINT D: 9.6% (Schedule 13G/A, filed Aug 14, 2026)
- Palogic Value Management, LP: 7.1% (Schedule 13D/A, filed Sep 8, 2026)
- Impax Asset Management Group plc: 5.4% (Schedule 13G, filed Jul 21, 2026)